FTC Tells 3rd Circ. AbbVie Pay-For-Delay Case Axed Too Early
The Federal Trade Commission urged the Third Circuit to revive the agency's antitrust claim that AbbVie paid off Teva Pharmaceuticals to delay Teva's generic version of the testosterone treatment AndroGel, saying...To view the full article, register now.
Already a subscriber? Click here to view full article